Ghost authorship of industry funded drug trials is common
   

Ghost authorship is the failure to name, as an author, an individual who has made a substantial contribution to a scientific article. A study of 44 industry-initiated trials from Denmark in the 1990s found evidence of ghost authorship for 33 trials, which increased to 40 if a person qualifying for authorship was just acknowledged rather than being named as an author.
   

[pranala luar disembunyikan, sila masuk atau daftar.]